COVID-19
Peer-reviewed study finds over 1,000% rise in cardiac deaths after COVID-19 shots
From LifeSiteNews
A new study published in the Journal of Emergency Medicine by a team of McCullough Foundation doctors reports significant links ‘between excess fatal cardiopulmonary arrests and the COVID-19 vaccination campaign.’
A new peer-reviewed study reports that it has found a more than 1,000 percent increase in heart-related deaths among a large pool of people who have taken the COVID-19 shots.
On October 24, the Journal of Emergency Medicine published a study by a team of McCullough Foundation doctors who reviewed the annual reports of cardiopulmonary arrests, survival rates, and emergency medical services (EMS) incidents from King County, Washington, from 2016 to 2023. The county presented a “unique opportunity” for analysis because nearly the entire population (an estimated 98%) had received at least one COVID shot dose.
“As of August 2nd, 2024, there have been approximately 589,247 confirmed COVID-19 cases in King County,” the study found.
“In 2021-2022, Total EMS attendances in King County sharply increased by 35.34% from 2020 and by 11% from pre-pandemic years. Cases of ‘obvious death’ upon EMS arrival increased by 19.89% in 2020, 36.57% in 2021, and 53.80% in 2022 compared to the 2017-2019 average. We found a 25.7% increase in total cardiopulmonary arrests and a 25.4% increase in cardiopulmonary arrest mortality from 2020 to 2023 in King County, WA.”
“Excess fatal cardiopulmonary arrests were estimated to have increased by 1,236% from 2020 to 2023, rising from 11 excess deaths (95% CI: -12, 34) in 2020 to 147 excess deaths (95% CI: 123, 170) in 2023,” the study continued. “A quadratic increase in excess cardiopulmonary arrest mortality was observed with higher COVID-19 vaccination rates. The general population of King County sharply declined by 0.94% (21,300) in 2021, deviating from the expected population size. Applying our model from these data to the entire United States yielded 49,240 excess fatal cardiopulmonary arrests from 2021-2023.”
The authors concluded that there was a “significant ecological and temporal association between excess fatal cardiopulmonary arrests and the COVID-19 vaccination campaign,” but allowed that “COVID-19 infection and disruptions in emergency care during the pandemic” could be an alternative explanation.
To more fully understand the problem, they called for “continuous monitoring and analysis of cardiopulmonary arrest data to inform public health interventions and policies, especially in the context of vaccination programs,” as well as for the “U.S. Centers for Disease Control and Prevention COVID-19 vaccination administration data [to] be merged with all death cases so that the vaccine type, dose(s), and date of administration can be analyzed as possible determinants.”
The study adds to a large body of evidence linking significant risks to the COVID shots, which were developed and reviewed in a fraction of the time vaccines usually take under the first Trump administration’s Operation Warp Speed initiative.
The federal Vaccine Adverse Event Reporting System (VAERS) reports 38,068 deaths, 218,646 hospitalizations, 22,002 heart attacks, and 28,706 myocarditis and pericarditis cases as of October 25, among other ailments. U.S. Centers for Disease Control & Prevention (CDC) researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.
An analysis of 99 million people across eight countries published February in the journal Vaccine “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID jabs, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 shots, and offered several theories for a causal link.
All eyes are currently on former President Donald Trump, who last week won his campaign to return to the White House and whose team, which will be helmed by prominent vaccine critic Robert F. Kennedy Jr. as his nominee for secretary of Health and Human Services, has given mixed signals as to the prospects of reconsidering the shots for which he has long taken credit. At the very least, Trump has consistently opposed jab mandates and is expected to fill more federal judicial vacancies with jurists similarly inclined.
COVID-19
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’
From LifeSiteNews
The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.
In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).
Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.
Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.
Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).
From LifeSiteNews
A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna
A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
Study Overview
- Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
- Intervention: Two doses of either:
- BNT162b2 (Pfizer-BioNTech)
- mRNA-1273 (Moderna)
- Follow-up Duration: 12 months after second dose.
- Comparison: Head-to-head between Pfizer vs. Moderna recipients.
- Main Outcomes:
- All-cause mortality
- Cardiovascular mortality
- COVID-19 mortality
- Non-COVID-19 mortality
All-cause mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
- Pfizer Risk: 847.2 deaths per 100,000 people
- Moderna Risk: 617.9 deaths per 100,000 people
- Risk Difference:
➔ +229.2 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer) - Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
- Pfizer Risk: 248.7 deaths per 100,000 people
- Moderna Risk: 162.4 deaths per 100,000 people
- Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk) - Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
- Pfizer Risk: 55.5 deaths per 100,000 people
- Moderna Risk: 29.5 deaths per 100,000 people
- Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk) - Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
- Pfizer Risk: 791.6 deaths per 100,000 people
- Moderna Risk: 588.4 deaths per 100,000 people
- Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk) - Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
- Different lipid nanoparticle compositions
- Differences in manufacturing, biodistribution, or storage conditions
Final conclusion
Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.
Reprinted with permission from Focal Points.
New Alberta Election Act bans electronic vote counting machines, lowers threshold for recalls and petitions
Hours after Liberal election win, Alberta Prosperity Project drumming up interest in referendum
NDP Floor Crossers May Give Carney A Majority
It’s On! Alberta Challenging Liberals Unconstitutional and Destructive Net-Zero Legislation
-
Alberta2 days ago
It’s On! Alberta Challenging Liberals Unconstitutional and Destructive Net-Zero Legislation
-
Alberta2 days agoAlberta’s future in Canada depends on Carney’s greatest fear: Trump or Climate Change
-
2025 Federal Election1 day agoThe Liberals torched their own agenda just to cling to power
-
Agriculture2 days agoLiberal win puts Canada’s farmers and food supply at risk
-
Crime10 hours agoCanada Blocked DEA Request to Investigate Massive Toronto Carfentanil Seizure for Terror Links
-
Business1 day agoTrump says he expects ‘great relationship’ with Carney, who ‘hated’ him less than Poilievre
-
Business1 day agoCanada urgently needs a watchdog for government waste
-
International2 days agoNigeria, 3 other African countries are deadliest for Christians: report